Fluctuations in exhaled hydrogen gas due to oral administration of fructooligosaccharides

Assessment of fluctuations in exhaled hydrogen gas due to oral administration of fructooligosaccharides

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs021220023

Enrollment

100

Registered

2022-09-22

Start date

2022-09-22

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

threatened preterm birth

Interventions

Intake of fluctoligosaccharides

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1) Maternal age: 18 years old and over, under 50 years old 2) 50 healthy women without complications 3) 50 pregnant women who are planning to deliver at our department.

Exclusion criteria

Exclusion criteria: If not gain consent

Design outcomes

Primary

Measure	Time frame
1) Make healthy women take fluctoligosaccharides, assesment of increase experhal hydrogen and the degree 2) Make pregnant women take fluctoligosaccharides, assesment of increase experhal hydrogen and the degree	—

Secondary

Measure	Time frame
Evaluation of side effects and other safety caused by fructooligosaccharide	—

Contacts

Public ContactHiroshi Miura

Akita University Hospital

miurah@doc.med.akita-u.ac.jp+81-18-884-6163

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026